Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The hydrogel effectively improves diabetic wound healing by reducing inflammation and promoting tissue repair.

Negative pressure fractional microneedle radiofrequency effectively and safely reduces periorbital aging signs.

Immunological treatment improved both neuropathy and alopecia.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Stem cell vesicles reduced eczema symptoms in mice safely.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Combining minoxidil and fibroblast growth factor is more effective for treating male hair loss than using either alone.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

miR-182 may help treat hallux valgus by targeting FGF9.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Reducing neutrophils or inhibiting NETs improves wound healing in sickle cell disease.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Collaboration among experts is crucial to design hydrogels that improve immune therapies.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

bFGF delays hair growth in mice.

The hydrogel effectively treats oral mucositis by reducing oxidative damage and bacterial infection.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.

ILC1-like cells may contribute to hair loss in alopecia areata.

EGFR is essential for normal hair development and follicle differentiation.

GABAergic steroid precursors reduce ethanol withdrawal symptoms in certain mice.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Microneedling with CGF significantly improves hair regrowth in androgenetic alopecia.